Benzinga
Benzinga
Benzinga
miércoles, septiembre 23

Edwards Lifesciences Corp

EWNYSE
Trade with Public
Trade with Public
$88.78
0.440.5%
al cierre: Sep 22, 5:00 PM EST
$88.78
N/A
After hour: 4:34 PM EST
Panorámica generalNoticiasPrevisión de beneficiosEventosPrecios objetivoFinanzasSentimientoPropiedadCompararOpcionesInforme de acciones

Edwards Lifesciences Analyst Price Targets

Wall Street analyst price targets and consensus rating for Edwards Lifesciences (EW).

Price Target Range — 8 Quarters

Analyst Consensus — 20 Analysts

17Buy
3Hold
Consensus RatingBuy# Analysts20Avg. Consensus PT$100Upside to Avg. PT+12.4%

Rating Trend — Last 9 Months

Recent Analyst Actions

Ver todas las valoraciones →
DateFirmAnalystActionRating ChangePrice Target
Sep 11, 2026BTIGMarie ThibaultMaintainedBuy$110
Jul 28, 2026UBSPatrick WoodAssumesNeutral→Buy$110
More with Benzinga EdgeGet Access

Analyst Ratings News

PRO
BTIG Reiterates Buy on Edwards Lifesciences, Maintains $110 Price Target

BTIG analyst Marie Thibault reiterates Edwards Lifesciences (NYSE:EW) with a Buy and maintains $110 price target.
Benzinga Newsdesk

PRO
JP Morgan Maintains Overweight on Edwards Lifesciences, Raises Price Target to $105

JP Morgan analyst Robbie Marcus maintains Edwards Lifesciences (NYSE:EW) with a Overweight and raises the price target from $100 to $105.
Benzinga Newsdesk

PRO
Piper Sandler Reiterates Overweight on Edwards Lifesciences, Raises Price Target to $101

Piper Sandler analyst Adam Maeder reiterates Edwards Lifesciences (NYSE:EW) with a Overweight and raises the price target from $100 to $101.
Benzinga Newsdesk

Edwards Earnings Add Fuel To Bullish MedTech Thesis, Analyst Says

Edwards Lifesciences tops Q2 Wall Street estimates with $1.74B in revenue. EW stock jumps as analysts see continued upside ahead.
Vandana Singh

PRO
Truist Securities Maintains Hold on Edwards Lifesciences, Raises Price Target to $95

Truist Securities analyst Richard Newitter maintains Edwards Lifesciences (NYSE:EW) with a Hold and raises the price target from $90 to $95.
Benzinga Newsdesk

PRO
Mizuho Maintains Outperform on Edwards Lifesciences, Raises Price Target to $105

Mizuho analyst Anthony Petrone maintains Edwards Lifesciences (NYSE:EW) with a Outperform and raises the price target from $100 to $105.
Benzinga Newsdesk

Datos y APIs: APIs de Benzinga · API de noticias de acciones · API de calificaciones de analistas · API de logotipos de empresas

Datos de mercado proporcionados por APIs de Benzinga

Benzinga

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL

© 2026 Benzinga | All Rights Reserved